Effective Vaccine for Malaria a Step Closer
Topic: Immunization and Vaccines
Author: The Walter and Eliza Hall Institute of Medical Research
Published: 2010/09/25
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: Vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells.
Introduction
Malaria's newest pathway into human cells identified.Main Item
Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute, provides a new vaccine target through which infection with the deadly disease could be prevented.
Each year more than 400 million people contract malaria, and more than one million, mostly children, die from the disease. The most lethal form of malaria is caused by the parasite Plasmodium falciparum. Part of the parasite's success lies in its ability to deploy multiple ways to invade red blood cells, a process essential for the survival of the parasite within the human host.
Professor Alan Cowman, head of the institute's Infection and Immunity division, led the research with Dr Wai-Hong Tham, Dr Danny Wilson, Mr Sash Lopaticki, Mr Jason Corbin, Dr Dave Richard, Dr James Beeson from the institute and collaborators at the University of Edinburgh.
For decades, it has been known that malaria parasites use proteins called glycophorins as a means of entering red blood cells. This new research reveals an alternative pathway used by the parasite to enter red blood cells. The pathway does not involve glycophorins, instead requiring the binding of a parasite molecule named PfRh4 to Complement Receptor 1 (CR1), a common protein found on the surface of red blood cells.
"The parasite is like a master burglar - it will try a variety of different methods to get into the house, not just the front door," Professor Cowman said. "Although the human body has evolved a variety of methods to keep the parasite out, it keeps finding new ways to get in."
Professor Cowman said the PfRh family of surface proteins is involved in the recognition of red blood cell receptors, which allows the parasite to attach to the red blood cell surface and gain entry.
"We think that the parasite uses this protein to correctly identify the red blood cell and say 'Yes, this is the one we want to invade', it's like a quality assurance process," Professor Cowman said.
"The PfRh4-CR1 pathway is one of the most important of the pathways we've identified for entry of malaria parasites into cells," Professor Cowman said. "We are now at the stage where we have identified the best combination of proteins for a vaccine, and are ready to start clinical development.
"When both glycophorin and CR1 pathways are blocked, there is a 90 percent decrease in infection of the cells with the parasite. These results suggest that if a vaccine were to stimulate the immune system to recognize and generate antibodies to the prevalent invasion pathways, there is a good chance it would lead to a significant decrease in malaria infection."
The research was published this week in the journal Proceedings of the National Academy of Sciences USA. The study was supported by the National Health and Medical Research Council of Australia, the Darwin Trust of Edinburgh, the Wellcome Trust and the Victorian Government.
Explore Related Topics
1 - Reevaluating Misinformation: The Role of Unflagged, Accurate Content in Fueling Vaccine Hesitancy - Vaccine-skeptical content that is not being flagged by Facebook is potentially lowering users intentions to get vaccinated by 2.3 percentage points.
2 - Diverse Range of Vaccines Crucial For Bird Flu Pandemic Preparedness - Diverse range of vaccines platforms crucial for enhancing human pandemic preparedness following discovery of a second case of avian influenza spreading from cows to humans.
3 - Vast Majority of Global Population Trust Vaccines - Survey across 23 countries reveals substantial trust in vaccines among a large segment of the global population.
4 - Vaccination and Boosters During Pregnancy Benefits Pregnant Women and Newborns - Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to recent findings.
5 - New Guidance on Safe Injection Practice in Hospitals - New guidance on safe injection practice in hospitals emphasises the importance of prefilled and labelled syringes in avoiding medication errors.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): The Walter and Eliza Hall Institute of Medical Research. (2010, September 25). Effective Vaccine for Malaria a Step Closer. Disabled World. Retrieved October 5, 2024 from www.disabled-world.com/medical/immunization/malaria-vaccine.php
Permalink: <a href="https://www.disabled-world.com/medical/immunization/malaria-vaccine.php">Effective Vaccine for Malaria a Step Closer</a>: Vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.